Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8
Ying Li, Sisi Chen, Jianyu Zhu, Chanjuan Zheng, Muyao Wu, Lian Xue, Guangchun He, Shujun Fu, Xiyun Deng
Topics & Concepts
PaclitaxelProstate cancerMedicineProstateChemotherapyCancerPharmacologyCancer researchTaxaneInternal medicineOncologyBreast cancerCancer, Lipids, and MetabolismLipoproteins and Cardiovascular HealthInflammatory mediators and NSAID effects